You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 1 Issues Articles
Popular Type 1 Issues Articles
Highly Recommended Type 1 Issues Articles
Send a link to this page to your friends and colleagues.
In a small study conducted by researchers in the Netherlands, a drug normally used to treat asthma and bronchitis helped to improve awareness of hypoglycemia in people with type 1 diabetes. Hypoglycemia unawareness can be a dangerous condition—a person with diabetes who cannot detect an episode of low blood glucose cannot take quick action to correct it.
The drug, called theophylline, improved adrenaline response and decreased blood flow in the brain, resulting in stronger responses to and earlier awareness of decreasing glucose levels, according to the study, which was published in the March 2002 issue of Diabetes.
The adrenal glands of the group that received theophylline responded "significantly" more than those of the control group. The theophylline group also began to sweat more at higher blood-glucose levels and exhibited less blood flow in the brain—factors that help subjects to be aware of low blood glucose, note the researchers.
Researchers conclude that the drug improved both counter-regulatory responses and detection of low blood glucose in people with diabetes and impaired hypoglycemia awareness.
0 comments - Jun 1, 2002
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.